All Comments by Lary Walker

  1. Gamma-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway.
  2. Traveling Tau—A New Paradigm for Tau- and Other Proteinopathies?
  3. A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.
  4. Driving amyloid toxicity in a yeast model by structural changes: a molecular approach.
  5. Conformational diversity of wild-type Tau fibrils specified by templated conformation change.
  6. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease.
  7. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.
  8. Effect of infarcts on dementia in the Baltimore longitudinal study of aging.
  9. Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid.
  10. Participation in dementia research: rates and correlates of capacity to give informed consent.
  11. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
  12. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.
  13. Visualization and classification of amyloid beta supramolecular assemblies.
  14. Persistence of contradicted claims in the literature.
  15. The Brain and Microglial Recruitment—Think Local, Not Global